Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kleber Y Fertrin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Hematology. American Society of Hematology. Education Program|December 4, 2020
Updates on the diagnosis and management of the most common hereditary porphyrias: AIP and EPPMichael Linenberger, Kleber Y Fertrin
Clinics in Laboratory Medicine|November 3, 2024
History, Advances, and Challenges of Sickle Cell Disease TreatmentRitika Walia, Kleber Y Fertrin, Daniel E Sabath
Clinics in Laboratory Medicine|November 3, 2024
A Winding Road to Health Care Equity in Sickle Cell DiseaseRitika Walia, Kleber Y Fertrin, Daniel E Sabath
Hepatology Communications|June 14, 2022
Iron overload disordersChristine C Hsu, Nizar H Senussi, Kleber Y Fertrin, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2016
Sickle Cell Imaging Flow Cytometry Assay (SIFCA)Kleber Y Fertrin, Leigh Samsel, Eduard J van Beers, et al.
British Journal of Haematology|July 14, 2022
Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS studyNicola Conran, Claudia de Alvarenga Maximo, Thais Oliveira, et al.
Transfusion|April 30, 2025
Alloimmunization as a barrier to gene therapy in sickle cell diseaseHannah R Abrams, Nabiha H Saifee, William S Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 21, 2024
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosisOyebimpe O Adesina, Isaac C Jenkins, Fábio Galvão, et al.
Annals of Hematology|September 8, 2019
Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patientsOladele Simeon Olatunya, Carolina Lanaro, Ana Leda Longhini, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 2, 2019
Different morphological and gene expression profile in placentas of the same sickle cell anemia patient in pregnancies of opposite outcomesLetícia C Baptista, Camilla O Figueira, Bruno B Souza, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Hematology. American Society of Hematology. Education Program|December 4, 2020
Updates on the diagnosis and management of the most common hereditary porphyrias: AIP and EPPMichael Linenberger, Kleber Y Fertrin
Clinics in Laboratory Medicine|November 3, 2024
History, Advances, and Challenges of Sickle Cell Disease TreatmentRitika Walia, Kleber Y Fertrin, Daniel E Sabath
Clinics in Laboratory Medicine|November 3, 2024
A Winding Road to Health Care Equity in Sickle Cell DiseaseRitika Walia, Kleber Y Fertrin, Daniel E Sabath
Hepatology Communications|June 14, 2022
Iron overload disordersChristine C Hsu, Nizar H Senussi, Kleber Y Fertrin, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2016
Sickle Cell Imaging Flow Cytometry Assay (SIFCA)Kleber Y Fertrin, Leigh Samsel, Eduard J van Beers, et al.
British Journal of Haematology|July 14, 2022
Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS studyNicola Conran, Claudia de Alvarenga Maximo, Thais Oliveira, et al.
Transfusion|April 30, 2025
Alloimmunization as a barrier to gene therapy in sickle cell diseaseHannah R Abrams, Nabiha H Saifee, William S Miller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 21, 2024
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosisOyebimpe O Adesina, Isaac C Jenkins, Fábio Galvão, et al.
Annals of Hematology|September 8, 2019
Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patientsOladele Simeon Olatunya, Carolina Lanaro, Ana Leda Longhini, et al.
Experimental Biology and Medicine (Maywood, N.J.)|March 2, 2019
Different morphological and gene expression profile in placentas of the same sickle cell anemia patient in pregnancies of opposite outcomesLetícia C Baptista, Camilla O Figueira, Bruno B Souza, et al.
Pageof 2